Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Cash from Financing Activities (2016 - 2026)

Healthequity has reported Cash from Financing Activities over the past 14 years, most recently at -$99.8 million for Q1 2026.

  • Quarterly results put Cash from Financing Activities at -$99.8 million for Q1 2026, down 12.9% from a year ago — trailing twelve months through Jan 2026 was -$387.0 million (down 772.22% YoY), and the annual figure for FY2026 was -$387.0 million, down 772.22%.
  • Cash from Financing Activities for Q1 2026 was -$99.8 million at Healthequity, up from -$122.4 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for HQY hit a ceiling of $176.6 million in Q3 2024 and a floor of -$122.4 million in Q4 2025.
  • Median Cash from Financing Activities over the past 5 years was -$3.0 million (2022), compared with a mean of -$22.5 million.
  • Peak annual rise in Cash from Financing Activities hit 8295.68% in 2024, while the deepest fall reached 4163.86% in 2024.
  • Healthequity's Cash from Financing Activities stood at -$1.1 million in 2022, then skyrocketed by 285.21% to $2.0 million in 2023, then tumbled by 4163.86% to -$82.4 million in 2024, then tumbled by 48.51% to -$122.4 million in 2025, then grew by 18.45% to -$99.8 million in 2026.
  • The last three reported values for Cash from Financing Activities were -$99.8 million (Q1 2026), -$122.4 million (Q4 2025), and -$108.1 million (Q3 2025) per Business Quant data.